Record Information
Version1.0
StatusDetected and Quantified
Creation Date2020-12-10 18:38:23 UTC
Update Date2024-04-30 19:32:29 UTC
Metabolite IDMMDBc0000465
Metabolite Identification
Common NameCarglumic acid
DescriptionCarglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death. Carglumic acid was approved by the U.S. Food and Drug Administration (FDA) on 18 March 2010.
Structure
Synonyms
ValueSource
(2S)-2-(Carbamoylamino)pentanedioic acidChEBI
Acide carglumiqueChEBI
Acido carglumicoChEBI
Acidum carglumicumChEBI
CarbagluChEBI
Carbamino-L-glutamic acidChEBI
Carbamylglutamic acidChEBI
L-N-Carbamoylglutamic acidChEBI
Ureidoglutaric acidChEBI
(2S)-2-(Carbamoylamino)pentanedioateGenerator
Carbamino-L-glutamateGenerator
CarbamylglutamateGenerator
L-N-CarbamoylglutamateGenerator
UreidoglutarateGenerator
CarglumateGenerator
(S)-2-Ureidopentanedioic acidHMDB
N-Carbamoyl-L-glutamic acidHMDB
N-Carbamyl-L-glutamateHMDB
N-CarbamylglutamateHMDB
N-Carbamoyl-L-glutamateHMDB
N-CarbamoylglutamateHMDB
Molecular FormulaC6H10N2O5
Average Mass190.154
Monoisotopic Mass190.05897144
IUPAC Name(2S)-2-(carbamoylamino)pentanedioic acid
Traditional Namecarglumic acid
CAS Registry NumberNot Available
SMILES
NC(=O)N[C@@H](CCC(O)=O)C(O)=O
InChI Identifier
InChI=1S/C6H10N2O5/c7-6(13)8-3(5(11)12)1-2-4(9)10/h3H,1-2H2,(H,9,10)(H,11,12)(H3,7,8,13)/t3-/m0/s1
InChI KeyLCQLHJZYVOQKHU-VKHMYHEASA-N